A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.

OBJECTIVES: To assess the efficacy and safety of adefovir dipivoxil (ADV) added to stable background antiretroviral therapy (ART) in HIV-infected individuals with advanced HIV disease. METHODS: ADHOC was a randomized, double-blind, placebo-controlled, international multicentre trial. Three hundred...

詳細記述

書誌詳細
第一著者: ADHOC International Steering Committee
フォーマット: Journal article
言語:English
出版事項: 2002

類似資料